This one day conference will cover methods of treatment, basics of clinical trials, advances in radiation treatment, survivors and survivorship care. The conference is designed for physicians, nurses, and advanced practice professionals involved in women’s healthcare who have an interest in the management of quality of life challenges for the breast cancer survivor as well as current breast cancer therapies and multidisciplinary management.
This weekend course was designed to provide a comprehensive and practical update on strategies for efficient detection and characterization of degenerative and traumatic conditions of the musculoskeletal system (spine, upper and lower extremity) with MRI. The faculty will consist of 5 experienced radiologists as well as an expert orthopedic surgeon, all of whom are noted for their lecturing and teaching ability. The course was designed to allow interaction and questions with the faculty.
This course offers a unique opportunity to learn from and interact with the country's leading experts in EBUS and navigation bronchoscopy with hands-on practice on animals and state-of-the-art simulators. This course is going to be held at Trent Semans Center, Great Hall on September 13, 2019. The lectures and interactive didactic sessions will cover a range of topics including transbronchial needle aspiration, endoscopic ultrasound, navigational bronchoscopy, and staging of lung cancer.
This is a study to investigate the potential clinical benefit of trilaciclib (G1T28) in preserving the bone marrow and the immune system, and enhancing chemotherapy antitumor efficacy when administered prior to topotecan in patients previously treated for extensive-stage SCLC. The study consists of 2 parts: a limited open-label, dose-finding portion (Part 1), and a randomized double-blind portion (Part 2). Both parts include 3 study phases: Screening Phase, Treatment Phase, and Survival Follow-up Phase. The Treatment Phase begins on the day of the first dose with study treatment and completes at the Post-Treatment Visit. The open-label portion enrolled 32 patients and the randomized portion will enroll approximately 90 patients.
This study examines the aphasia treatment response among Veterans and non-Veterans living with aphasia. It seeks to identify cognitive and neural factors which are predictive of positive response to treatment targeting naming impairments in aphasia. It also examines the dose-response relationship for naming treatment. More broadly, it seeks to determine who aphasia therapy works best for, and how much aphasia therapy is sufficient to achieve a positive treatment response.
This phase I/II trial studies the side effects and best dose of plinabulin when given together with nivolumab and to see how well they work in treating patients with stage IIIB-IV non-small cell lung cancer that has come back or spread to other places in the body. Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as plinabulin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving nivolumab and plinabulin together may work better at treating patients with non-small cell lung cancer.
This research study is looking at an antibiotic medicine, Ceftaroline Fosamil (Ceftaroline), which fights infections like the one you have. Ceftaroline is effective against S.aureus germs including those that are called methicillin-resistant S. aureus or Methicillin-Resistant Staphylococcus aureus (MRSA). The investigators are also studying what the body does to the study drug, Ceftaroline, and if the doses the investigators use the result in blood levels that the investigators think are going to be effective against bone infections in children.
A new study suggests that, Robbie an animated brain with other educational materials can help in promoting brain health in children. The research also states that the children were extremely happy with the animated video and it could actually reduce the risk of developing Dementia in later life.
According to a study published in Circulation, TTN or Titin in truncating variants showed an bnormal phenotype exemplified by lower left ventricular ejection fraction in patients regardless of their cardiomyopathy status. TTN gene in a highly expressed exon were seen in 1.2% of patients and the other group showed 0.6% variants.
According to findings published in Metabolism, Korean adults who had metabolic syndrome and obesity were more likely to be diagnosed with psoriasis as opposed to individuals who were metabolically healthy. Researchers also concluded that participants with more than three components of the metabolic syndrome were more likely to be diagnosed with Psoriasis.